STOCK TITAN

Cardlytics - CDLX STOCK NEWS

Welcome to our dedicated page for Cardlytics news (Ticker: CDLX), a resource for investors and traders seeking the latest updates and insights on Cardlytics stock.

Cardlytics (CDLX) delivers purchase-based advertising intelligence through partnerships with financial institutions, transforming consumer spending data into actionable marketing insights. This news hub provides investors and analysts with essential updates on the company’s evolving strategies in digital advertising and data analytics.

Access real-time announcements including quarterly earnings, product launches, and partnership expansions. Our curated collection features press releases about platform innovations, client acquisitions, and industry recognition – all critical developments for understanding CDLX’s market position.

Key updates cover operational milestones across both core platforms: the proprietary bank advertising channel and Bridg cloud-based analytics solutions. Track developments in campaign measurement capabilities, financial institution collaborations, and data security enhancements that shape the company’s competitive edge.

Bookmark this page for streamlined monitoring of CDLX’s financial performance and strategic initiatives. Combine our news feed with SEC filings and earnings call transcripts available through Stock Titan’s financial research tools for comprehensive analysis.

Rhea-AI Summary
Cardlytics, Inc. (NASDAQ: CDLX) granted 198,183 restricted stock units to 8 new employees as inducements to employment under the 2022 Inducement Plan. The units have varying vesting schedules, with some vesting 100% on the first anniversary and others vesting 50% initially and the remaining 50% quarterly over the subsequent year.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.06%
Tags
none
-
Rhea-AI Summary
Cardlytics, Inc. (NASDAQ: CDLX) announced the release of its fourth-quarter financial results on March 14, 2024, followed by a conference call to discuss the company's performance.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.21%
Tags
-
Rhea-AI Summary
Cardlytics, Inc. expects to achieve positive adjusted EBITDA for full year 2023, which would allow it to extend the maturity date of its credit facility until April 2025. The company entered into a settlement agreement with Shareholder Representative Services LLC, resolving all disputes related to the Bridg merger agreement and reported preliminary financial results for the fourth quarter ended December 31, 2023. The settlement agreement includes a cash payment of $25 million and issuance of 3.6 million shares of Cardlytics common stock to SRS. The company anticipates billings, revenue, adjusted contribution, and adjusted EBITDA to meet or exceed previous guidance for Q4 2023, indicating sustained profitability and flexibility in credit facility maturity.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
24.61%
Tags
Rhea-AI Summary
Cardlytics, Inc. (NASDAQ: CDLX) appoints Andre Fernandez and Jon Francis to its Board of Directors while John Balen and David Adams retire. Jack Klinck assumes the role of Chairperson of the Board. The new appointees bring expertise in financial strategy and data-driven analytics. Fernandez has leadership experience at WeWork, NCR, and General Electric, while Francis is the Chief Data and Analytics Officer at General Motors.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.36%
Tags
management
-
Rhea-AI Summary
Cardlytics (NASDAQ: CDLX) Renews Spending Rewards Agreement with Lloyds Bank Plc
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.3%
Tags
none
-
Rhea-AI Summary
Augeo (NASDAQ: AUG) subsidiary Kigo acquires Entertainment® from Cardlytics, Inc. to revolutionize loyalty engagement. Augeo celebrates 18 years of growth, nearing half a billion in annual revenue. The acquisition enhances Kigo's mission to deliver personalized, localized, and relevant rewards through universal loyalty wallet technology.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.1%
Tags
Rhea-AI Summary
Cardlytics, Inc. (NASDAQ: CDLX) announced Q3 2023 financial results, reporting $79.0 million in revenue, a 9% YoY increase, and a net loss of $(24.0) million. Key metrics include 162.5 million MAUs and Q4 2023 guidance of $122.0 - $133.0 million in billings.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-54.45%
Tags
-
Rhea-AI Summary
Cardlytics, Inc. grants 305,800 restricted stock units to 10 newly hired employees as material inducements to employment. The units were granted under the 2022 Inducement Plan with different vesting schedules.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.69%
Tags
none
-
Rhea-AI Summary
Cardlytics, Inc. (NASDAQ: CDLX) will release its Q3 2023 financial results on November 8, 2023, after market close. The company will host a conference call and webcast to discuss the results.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.34%
Tags
Rhea-AI Summary
Cardlytics appoints Alex Mishurov as independent member of its Board of Directors. Cooperation agreement with CAS Investment Partners. Mishurov's insights expected to support continued growth and product innovation. Mishurov commended for his business acumen and expected to be an excellent representative for stockholders. Mishurov's role at KPS Global Asset Management and previous experience in financial industry highlighted. Cooperation agreement includes customary provisions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.62%
Tags
management
Cardlytics

Nasdaq:CDLX

CDLX Rankings

CDLX Stock Data

78.26M
50.83M
5.12%
57.68%
17.68%
Advertising Agencies
Services-computer Programming, Data Processing, Etc.
Link
United States
ATLANTA